1.16% 0.0111

Scilex Holding Company (SCLX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché SCLX Giù? Forum Previsione

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Scilex Holding Company Stock (SCLX) Company Profile

Scilex Holding Company

Healthcare (1179)

(650) 516-4310

960 SAN ANTONIO ROAD, PALO ALTO

Prossima data di guadagno

Ultimi documenti SEC

SCLX's Discussions on Twitter

Scilex Holding Company Borsa (SCLX) Ultime notizie

Scilex Holding Company Azioni (SCLX) Dati Finanziari

Scilex Holding Company Azioni (SCLX) insider trading

Commercio interno	Relazione	Data	Transazione	Costo	#Azioni	Valore ($)	#Azioni Totale
SHAH JAISIM	See Remarks	Oct 29 '24	Buy	0.99	32,000	31,670	109,333
Followwill Dorman	Director	Oct 18 '24	Buy	0.99	1,000	990	2,300
Chun Jay	Director	Oct 18 '24	Buy	0.95	5,000	4,750	112,500
Wu Yue Alexander	Director	Oct 17 '24	Buy	0.95	20,000	18,992	25,000
Lemus David	Director	Oct 17 '24	Buy	0.90	2,000	1,800	2,000
Ji Henry	Executive Chairperson	Oct 17 '24	Buy	0.97	10,000	9,710	60,070
SHAH JAISIM	See Remarks	Oct 16 '24	Buy	0.99	30,000	29,751	77,333
Ma Stephen Hoi	Chief Financial Officer	Oct 16 '24	Buy	0.97	6,700	6,499	22,840
Followwill Dorman	Director	Jun 26 '24	Option Exercise	1.37	1,000	1,370	1,300
Wu Yue Alexander	Director	Jun 20 '24	Option Exercise	1.41	5,000	7,050	5,000

Scilex Holding Company (SCLX)

Scilex Holding Company Stock (SCLX) Company Profile

Scilex Holding Company Borsa (SCLX) Ultime notizie

Scilex Pharmaceuticals announces end of phase II meeting with FDA for SP-103 - MSN

Scilex holding's CEO Jaisim Shah buys $31,670 worth of shares - Investing.com India

Pleasing Signs As A Number Of Insiders Buy Scilex Holding Stock - Yahoo Finance

Scilex Pharmaceuticals Inc, a Wholly Owned Subsidiary of - GlobeNewswire

Scilex Pharmaceuticals Inc, a Wholly Owned Subsidiary of Scilex Holding Company, Announces Successful End of Phase II Meeting with FDA Leading to an Agreed Path Forward to NDA Upon Completion of Phase III Trials for Blockbuster Product Candidate, - Yahoo Finance

Scilex holding's CEO Jaisim Shah buys $31,670 worth of shares By Investing.com - Investing.com Canada

Jaisim Shah Acquires 32,000 Shares of Scilex Holding (NASDAQ:SCLX) Stock - MarketBeat

Scilex Holding Company, Following its Prior Announcement of the Record Date for a Dividend of Preferred Stock, Reiterates Information Previously Provided to Scilex Stockholders Regarding Manipulative and Naked Short Selling of Scilex Common Stock - ForexTV.com

Scilex Holding Company, Following its Prior Announcement of - GlobeNewswire

Scilex Holding Sets Dividend for Preferred Stock Exchange - TipRanks

Scilex Holding Company sets November 7, 2024 as the Record - GlobeNewswire

Scilex Holding Company sets November 7, 2024 as the Record Date for a Dividend of Preferred Stock Exchangeable for up to 10% of Scilex’s Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary - GlobeNewswire Inc.

Alliance Global Partners Begins Coverage on Scilex (NASDAQ:SCLX) - Defense World

Scilex gains on spinoff plans for pharma subsidiary - MSN

Scilex director Followwill Dorman buys $990 in common stock By Investing.com - Investing.com South Africa

Scilex director Followwill Dorman buys $990 in common stock - Investing.com

Scilex director Chun Jay acquires $4,750 in common stock - Investing.com

Holding Company Shares Rally Following Board Of Directors Commentary - MSN

Scilex Holding (NASDAQ:SCLX) Director Yue Alexander Wu Acquires 20,000 Shares - MarketBeat

Scilex holding's executive chairperson Ji Henry buys $9,710 in stock - Investing.com

Scilex director Wu Yue Alexander buys $18,992 in common stock By Investing.com - Investing.com South Africa

Scilex director Wu Yue Alexander buys $18,992 in common stock - Investing.com India

Scilex holding's executive chairperson Ji Henry buys $9,710 in stock By Investing.com - Investing.com UK

Scilex director Chun Jay acquires $4,750 in common stock By Investing.com - Investing.com Australia

Scilex CFO Stephen Hoi purchases $6,499 in common stock - Investing.com India

Scilex Holding's CEO Jaisim Shah purchases $29,751 in common stock - Investing.com India

Scilex Holding's CEO Jaisim Shah purchases $29,751 in common stock By Investing.com - Investing.com Canada

Jaisim Shah Purchases 30,000 Shares of Scilex Holding (NASDAQ:SCLX) Stock - MarketBeat

Scilex CFO Stephen Hoi purchases $6,499 in common stock By Investing.com - Investing.com UK

Scilex Explores Strategic Options, Analyst Initiates On Blockbuster Potential For Sciatica Pain Candidate - Benzinga

TSX Energy Capped Index (TTEN) QuotePress Release - The Globe and Mail

Scilex Holding looks to separate Scilex Pharma through potential spinout, IPO - FiercePharma

Scilex stock gains on spinoff plans (SCLX:NASDAQ) - Seeking Alpha

Scilex Holding explores spinoff for subsidiary Scilex Pharma - Investing.com

Scilex Holding Company Announces that its Board of Directors has Authorized Management to Explore Ways to Maximize the Value of its Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., including by way of conducting a spinoff or public listing of securit - The Manila Times

Scilex Holding explores spinoff for subsidiary Scilex Pharma By Investing.com - Investing.com South Africa

Scilex Holding Company Announces that its Board of - GlobeNewswire

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, Provides Timing to File in October 2024 a Registration Statement on Form S-4 with the SEC relating to the Previously Announced Proposed Business Combination Betwee - The Manila Times

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of - GlobeNewswire

Understanding the Risks of Investing in Scilex Holding Company (SCLX) - Knox Daily

Ratios Reveal: Breaking Down Scilex Holding Company (SCLX)’s Financial Health - The Dwinnex

Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination - The Manila Times

SCLX: Financing Deal Puts Company in Good Shape - Smartkarma

SCLX Grows Sales and Improves Finances - MSN

Scilex Holding Company (NASDAQ: SCLX) Stock Could Be An Option To Consider - Stocks Register

Scilex Holding Company [SCLX] Records 200-Day SMA of $1.3991 - Knox Daily

Scilex reports growth in Q3 net sales for pain management products - Investing.com Australia

Scilex reports growth in Q3 net sales for pain management products By Investing.com - Investing.com South Africa

Scilex Holding Company Provides Certain Preliminary Unaudited Financial Results for the Quarter Ended September 30, 2024 - ForexTV.com

Oramed Pharmaceuticals Reinforces Scilex Financial Ties - TipRanks

Scilex Holding Company Provides Certain Preliminary - GlobeNewswire

Scilex Holding Company Azioni (SCLX) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Scilex Holding Company Azioni (SCLX) insider trading

Simile a SCLX